KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-term Investments: 2020-2025

Historic Short-term Investments for Neogenomics (NEO) over the last 4 years, with Jun 2025 value amounting to $9.0 million.

  • Neogenomics' Short-term Investments fell 72.65% to $9.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.0 million, marking a year-over-year decrease of 72.65%. This contributed to the annual value of $19.8 million for FY2024, which is 72.73% down from last year.
  • As of Q2 2025, Neogenomics' Short-term Investments stood at $9.0 million, which was down 24.60% from $11.9 million recorded in Q1 2025.
  • Neogenomics' 5-year Short-term Investments high stood at $202.9 million for Q2 2021, and its period low was $9.0 million during Q2 2025.
  • Moreover, its 3-year median value for Short-term Investments was $42.8 million (2024), whereas its average is $58.4 million.
  • In the last 5 years, Neogenomics' Short-term Investments soared by 301.28% in 2021 and then crashed by 77.54% in 2025.
  • Over the past 5 years, Neogenomics' Short-term Investments (Quarterly) stood at $198.6 million in 2021, then decreased by 11.96% to $174.8 million in 2022, then crashed by 58.40% to $72.7 million in 2023, then tumbled by 72.73% to $19.8 million in 2024, then tumbled by 72.65% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q2 2025, $11.9 million for Q1 2025, and $19.8 million during Q4 2024.